Determining clinically meaningful decline in preclinical Alzheimer disease
Neurology Minute · American Academy of Neurology
July 23, 20191m 29s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.